150 related articles for article (PubMed ID: 2456047)
1. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
Davis JM; Koslow SH; Gibbons RD; Maas JW; Bowden CL; Casper R; Hanin I; Javaid JI; Chang SS; Stokes PE
Arch Gen Psychiatry; 1988 Aug; 45(8):705-17. PubMed ID: 2456047
[TBL] [Abstract][Full Text] [Related]
2. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
Arch Gen Psychiatry; 1983 Sep; 40(9):999-1010. PubMed ID: 6193764
[TBL] [Abstract][Full Text] [Related]
3. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
Stokes PE; Maas JW; Davis JM; Koslow SH; Casper RC; Stoll PM
Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
[TBL] [Abstract][Full Text] [Related]
4. Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression.
Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1261-71. PubMed ID: 7532316
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
[TBL] [Abstract][Full Text] [Related]
6. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
Curtin F; Walker JP; Schulz P
J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
[TBL] [Abstract][Full Text] [Related]
7. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
[TBL] [Abstract][Full Text] [Related]
8. Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites.
Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
Arch Gen Psychiatry; 1986 Oct; 43(10):1012-3. PubMed ID: 2428327
[No Abstract] [Full Text] [Related]
9. Biogenic amine metabolism in Tourette syndrome.
Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
[TBL] [Abstract][Full Text] [Related]
10. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
[TBL] [Abstract][Full Text] [Related]
11. High correlations of norepinephrine, dopamine, and epinephrine and their major metabolite excretion rates.
Linnoila M; Oliver J; Adinoff B; Potter WZ
Arch Gen Psychiatry; 1988 Aug; 45(8):701-4. PubMed ID: 3395200
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
[TBL] [Abstract][Full Text] [Related]
13. Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
Rosenthal NE; Davenport Y; Cowdry RW; Webster MH; Goodwin FK
Psychiatry Res; 1980 Mar; 2(1):113-9. PubMed ID: 6158064
[TBL] [Abstract][Full Text] [Related]
14. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.
Shekim WO; Dekirmenjian H; Chapel JL
Am J Psychiatry; 1977 Nov; 134(11):1276-9. PubMed ID: 910984
[TBL] [Abstract][Full Text] [Related]
15. Urinary noradrenaline and serotonin metabolites in drug-free Parkinson patients and the effect of L-dopa treatment.
Markianos M; Hadjikonstantinou M; Bistolaki E
Acta Neurol Scand; 1982 Aug; 66(2):267-75. PubMed ID: 6182730
[TBL] [Abstract][Full Text] [Related]
16. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls.
Roy A; Guthrie S; Karoum F; Pickar D; Linnoila M
Arch Gen Psychiatry; 1988 Feb; 45(2):158-61. PubMed ID: 3337613
[TBL] [Abstract][Full Text] [Related]
17. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
[TBL] [Abstract][Full Text] [Related]
18. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
Scheinin M
Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
[TBL] [Abstract][Full Text] [Related]
19. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
20. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.
Grossman F; Potter WZ
Psychiatry Res; 1999 Jul; 87(1):21-7. PubMed ID: 10512151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
